Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paari Murugan

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Chemical Research in Toxicology|April 21, 2022
The Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-<i>b</i>]pyridine Hair Dosimeter, DNA Adductomics Discovery, and Associations with Prostate Cancer Pathology BiomarkersJingshu Guo, Joseph S Koopmeiners, Scott J Walmsley, et al.
American Journal of Clinical Pathology|August 22, 2019
Prostate Biopsy ProcessingPaari Murugan, Dip Shukla, Jennifer Morocho, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2018
Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indicationsNiranjan J Sathianathen, Badrinath R Konety, Ayman Soubra, et al.
Urologic Oncology|February 25, 2019
Difference in MRI-guided biopsy cancer detection rates between individual cliniciansNiranjan J Sathianathen, Christopher A Warlick, Ayman Soubra, et al.
Head and Neck Pathology|May 25, 2026
A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous TransformationRayan M Sibira, Constance Chen, Felipe D' Almeida Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate CancerPaige M Glumac, Joseph P Gallant, Mariya Shapovalova, et al.
Chemical Research in Toxicology|November 10, 2017
A Rapid Throughput Method To Extract DNA from Formalin-Fixed Paraffin-Embedded Tissues for Biomonitoring Carcinogenic DNA AdductsByeong Hwa Yun, Shun Xiao, Lihua Yao, et al.
Oncogene|December 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic targetMarina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, et al.
World Journal of Urology|August 3, 2018
Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladderShaheen Alanee, Isabel Alvarado-Cabrero, Paari Murugan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 8, 2023
Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 CasesCarina A Dehner, Stephen M Broski, Jeanne M Meis, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Chemical Research in Toxicology|April 21, 2022
The Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-<i>b</i>]pyridine Hair Dosimeter, DNA Adductomics Discovery, and Associations with Prostate Cancer Pathology BiomarkersJingshu Guo, Joseph S Koopmeiners, Scott J Walmsley, et al.
American Journal of Clinical Pathology|August 22, 2019
Prostate Biopsy ProcessingPaari Murugan, Dip Shukla, Jennifer Morocho, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2018
Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indicationsNiranjan J Sathianathen, Badrinath R Konety, Ayman Soubra, et al.
Urologic Oncology|February 25, 2019
Difference in MRI-guided biopsy cancer detection rates between individual cliniciansNiranjan J Sathianathen, Christopher A Warlick, Ayman Soubra, et al.
Head and Neck Pathology|May 25, 2026
A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous TransformationRayan M Sibira, Constance Chen, Felipe D' Almeida Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate CancerPaige M Glumac, Joseph P Gallant, Mariya Shapovalova, et al.
Chemical Research in Toxicology|November 10, 2017
A Rapid Throughput Method To Extract DNA from Formalin-Fixed Paraffin-Embedded Tissues for Biomonitoring Carcinogenic DNA AdductsByeong Hwa Yun, Shun Xiao, Lihua Yao, et al.
Oncogene|December 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic targetMarina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, et al.
World Journal of Urology|August 3, 2018
Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladderShaheen Alanee, Isabel Alvarado-Cabrero, Paari Murugan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 8, 2023
Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 CasesCarina A Dehner, Stephen M Broski, Jeanne M Meis, et al.
Pageof 9